Veronika Dubajova

The Challenges Behind the COVID-19 Vaccines Rollout

Veronika Dubajova, Veronica, Liz

Global vaccination efforts require approximately 10 billion doses to immunize 5 billion adults, a volume driven by a massive U.S. target of 500 million doses and significant logistical challenges in both upstream supply and downstream distribution. While upstream constraints for vials and syringes have been largely mitigated through manufacturing scaling, downstream bottlenecks persist due to complex supply chains and variable cold-storage requirements that differ between Pfizer, Moderna, and AstraZeneca formulations. Current U.S. distribution is further complicated by vaccination hesitancy among only 30–50% of frontline staff and a temporary mismatch where 10 million administered doses remain unutilized, prompting the strategic release of withheld second-dose reserves to increase throughput.